vs
Side-by-side financial comparison of INNEOVA Holdings Ltd (INEO) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.
PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $30.8M, roughly 1.3× INNEOVA Holdings Ltd). INNEOVA Holdings Ltd runs the higher net margin — 0.8% vs -26.0%, a 26.7% gap on every dollar of revenue. INNEOVA Holdings Ltd produced more free cash flow last quarter ($-1.5M vs $-9.2M).
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
INEO vs PETS — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.8M | $40.7M |
| Net Profit | $243.0K | $-10.6M |
| Gross Margin | 19.3% | 23.3% |
| Operating Margin | 3.6% | -25.7% |
| Net Margin | 0.8% | -26.0% |
| Revenue YoY | — | -23.3% |
| Net Profit YoY | — | -1392.6% |
| EPS (diluted) | $0.02 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $40.7M | ||
| Q3 25 | — | $44.4M | ||
| Q2 25 | $30.8M | $51.2M | ||
| Q1 25 | — | $50.8M | ||
| Q4 24 | — | $52.0M | ||
| Q3 24 | — | $58.0M | ||
| Q2 24 | — | $66.2M | ||
| Q1 24 | — | $65.1M |
| Q4 25 | — | $-10.6M | ||
| Q3 25 | — | $-8.5M | ||
| Q2 25 | $243.0K | $-34.2M | ||
| Q1 25 | — | $-11.6M | ||
| Q4 24 | — | $-707.0K | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $3.8M | ||
| Q1 24 | — | $-5.0M |
| Q4 25 | — | 23.3% | ||
| Q3 25 | — | 28.0% | ||
| Q2 25 | 19.3% | 28.1% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | — | 32.3% | ||
| Q2 24 | — | 28.8% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | — | -25.7% | ||
| Q3 25 | — | -18.9% | ||
| Q2 25 | 3.6% | -66.7% | ||
| Q1 25 | — | -11.9% | ||
| Q4 24 | — | -0.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | -5.9% |
| Q4 25 | — | -26.0% | ||
| Q3 25 | — | -19.2% | ||
| Q2 25 | 0.8% | -66.7% | ||
| Q1 25 | — | -22.9% | ||
| Q4 24 | — | -1.4% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | -7.7% |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | — | $-0.41 | ||
| Q2 25 | $0.02 | $-1.65 | ||
| Q1 25 | — | $-0.56 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | — | $0.11 | ||
| Q2 24 | — | $0.18 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $26.9M |
| Total DebtLower is stronger | $2.9M | — |
| Stockholders' EquityBook value | $11.2M | $32.8M |
| Total Assets | $52.6M | $88.0M |
| Debt / EquityLower = less leverage | 0.26× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.9M | ||
| Q3 25 | — | $36.1M | ||
| Q2 25 | $2.1M | $41.1M | ||
| Q1 25 | — | $54.7M | ||
| Q4 24 | — | $50.1M | ||
| Q3 24 | — | $52.0M | ||
| Q2 24 | — | $46.0M | ||
| Q1 24 | — | $55.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $2.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $32.8M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | $11.2M | $51.5M | ||
| Q1 25 | — | $85.1M | ||
| Q4 24 | — | $96.2M | ||
| Q3 24 | — | $96.4M | ||
| Q2 24 | — | $93.5M | ||
| Q1 24 | — | $96.7M |
| Q4 25 | — | $88.0M | ||
| Q3 25 | — | $100.3M | ||
| Q2 25 | $52.6M | $109.8M | ||
| Q1 25 | — | $148.7M | ||
| Q4 24 | — | $144.8M | ||
| Q3 24 | — | $146.0M | ||
| Q2 24 | — | $152.7M | ||
| Q1 24 | — | $169.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-301.0K | $-9.2M |
| Free Cash FlowOCF − Capex | $-1.5M | $-9.2M |
| FCF MarginFCF / Revenue | -4.8% | -22.7% |
| Capex IntensityCapex / Revenue | 3.8% | 0.1% |
| Cash ConversionOCF / Net Profit | -1.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-23.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-9.2M | ||
| Q3 25 | — | $-2.2M | ||
| Q2 25 | $-301.0K | $-12.3M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $7.4M | ||
| Q2 24 | — | $-8.5M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | — | $-9.2M | ||
| Q3 25 | — | $-4.8M | ||
| Q2 25 | $-1.5M | $-13.6M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $6.1M | ||
| Q2 24 | — | $-9.2M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | — | -22.7% | ||
| Q3 25 | — | -10.8% | ||
| Q2 25 | -4.8% | -26.5% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | -3.7% | ||
| Q3 24 | — | 10.6% | ||
| Q2 24 | — | -13.9% | ||
| Q1 24 | — | 9.0% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | 3.8% | 2.5% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.18× | ||
| Q2 24 | — | -2.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INEO
Segment breakdown not available.
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
